Alessia Pin

Trieste, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Clinical phenotype and laboratory markers in patients affected by haploinsufficiency of A20 (HA20): a case series from two Italian centres.

Clinical phenotype and laboratory markers in patients affected by haploinsufficiency of A20 (HA20): a case series from two Italian centres.

Journal: RMD open

Published: January 25, 2026

Severe tenosynovitis with rapidly fluctuating power Doppler activity, a clue for the diagnosis of Blau syndrome: a case report.

Severe tenosynovitis with rapidly fluctuating power Doppler activity, a clue for the diagnosis of Blau syndrome: a case report.

Journal: Frontiers in pediatrics

Published: July 09, 2025

BCAP Is an Interferon-Stimulated Gene That Enhances Type I Interferon Activity in Response to Lipopolysaccharide.

BCAP Is an Interferon-Stimulated Gene That Enhances Type I Interferon Activity in Response to Lipopolysaccharide.

Journal: International journal of molecular sciences

Published: June 23, 2025

From DGCR8 expression analysis to diseased pathways in 22q11.2 deletion syndrome.

From DGCR8 expression analysis to diseased pathways in 22q11.2 deletion syndrome.

Journal: Frontiers in immunology

Published: April 14, 2025

Psoriatic arthritis spectrum in children: a multicentre observational study.

Psoriatic arthritis spectrum in children: a multicentre observational study.

Journal: Clinical and experimental rheumatology

Published: April 14, 2025

Study on mupirocin treatment in cutaneous lupus erythematosus: comment on the article by Abernathy-Close et al.

Study on mupirocin treatment in cutaneous lupus erythematosus: comment on the article by Abernathy-Close et al.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 19, 2024

Type I interferon signature: a quantitative standardized method for clinical application.

Type I interferon signature: a quantitative standardized method for clinical application.

Journal: Clinical and experimental immunology

Published: September 13, 2024

Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single-center experience.

Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single-center experience.

Journal: International journal of rheumatic diseases

Published: May 31, 2024

An easy assay to detect autoantibodies neutralizing cytokines in subjects with critical infections.

An easy assay to detect autoantibodies neutralizing cytokines in subjects with critical infections.

Journal: Journal of immunological methods

Published: September 06, 2023

A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome.

A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome.

Journal: Pulmonary circulation

Published: June 04, 2023

Inborn Errors of Immunity in Children with Autoimmune and Allergic Complaints: A Single Center Experience from Diagnosis to Treatment.

Inborn Errors of Immunity in Children with Autoimmune and Allergic Complaints: A Single Center Experience from Diagnosis to Treatment.

Journal: Biomedicines

Published: February 28, 2023

Type I interferon signature as a possible new marker for stratification of patients with juvenile idiopathic arthritis.

Type I interferon signature as a possible new marker for stratification of patients with juvenile idiopathic arthritis.

Journal: Clinical and experimental rheumatology

Published: October 01, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026